Testing a new tool to see retina in eye scans
Part of Eyes & vision clinical trials.
This trial is testing a new software tool that helps doctors see and assess different parts of the retina in eye scans. It aims to see how well the tool works in people with and without certain retina conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to attend all required study visits.
- You must be able to have an eye scan done.
- You may be in this trial if you have certain retina conditions (like fluid, damage, or thinning) OR if your retina looks healthy.
- You cannot have had a certain eye injection (Visudyne) in the past 48 hours.
- You must not have eye problems that would make the scans unclear, like dense cataracts or floaters.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new camera system to take pictures of the inside of the eye (the back part where the retina is). It is for people who have eye diseases like age-related macular degeneration, glaucoma, or diabetic retinopathy. The goal is to see how well the camera works in real-world conditions.
This trial tests whether a special eye scan (OCT) can help guide eye surgery during the operation. It may improve how surgeons see and target the exact eye structures they need to treat.
This trial tests a new medicine called EYE201/MK-8748 for people who have wet age-related macular degeneration (a condition where abnormal blood vessels grow under the retina). It's for those who haven't had treatment before and were diagnosed recently.
This trial studies whether a new, very high-resolution and high-speed eye scan can be used for people with eye problems or for healthy volunteers. It may help doctors better “see” eye structures more clearly to guide care.
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
This study tests a new eye imaging device to see if it can take clear pictures of the back of the eye. It may help doctors better see and monitor conditions like macular degeneration and diabetic retinopathy.
Hear when a new Epiretinal Membrane trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.